Bayer defeats malicious cyber attack

5 April 2019
bayer_flags_large

German pharma major Bayer (BAYN: DE) says it has neutralized a cyber threat present on its network for more than a year.

The firm reportedly had been quietly monitoring the malware, before deciding to remove it altogether. A spokesperson told Reuters there was “no evidence” that any data had been stolen, but that the impact was being evaluated.

The incident, which was originally reported by the German broadcasters BR and NDR, is believed to be typical of attacks coming out of China, although its origin has not been confirmed. German state prosecutors are said to have initiated their own investigation.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Today's issue

Company Spotlight





More Features in Pharmaceutical